ELAN PHARMA INTERNATIONAL LTD.
CIK 1307004 · last filed 2016-02-18
ELAN PHARMA INTERNATIONAL LTD. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing, for PTI, was dated Feb 18, 2016. Across all open-market trades the lifetime net is +$5.0M, making them a net buyer over the disclosed history. The firm reports its address in Dublin, L2. 11 SEC filings were submitted jointly with ELAN CORP PLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
1
$5.00M
Filer Profile
LOWER GRAND CANAL STREET
DUBLIN, L2 L2 2
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KINETA, INC./DE (PTI) Delisted | 10%+ Owner | 120,831 | — | — | $5.00M | 1 | 2016-02-18 |
Recent Filings
1 filing| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-18 | KINETA, INC./DE (PTI) Delisted | Mixed | +14,540,335 | $5.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.